Form 4: TD SYNNEX Director Sells Shares Under 10b5-1 Plan

TD SYNNEX Director Richard T. Hume executed pre-planned stock option exercises and subsequent sales of common stock in late January 2026.

Summary

• Richard T. Hume, a Director of TD SYNNEX CORP (SNX), reported transactions involving the company's common stock and employee stock options.
• On January 28, 2026, Mr. Hume exercised 12,991 employee stock options at a price of $107.32 per share, acquiring 12,991 shares of common stock.
• Immediately following the option exercise on January 28, 2026, Mr. Hume sold 12,745 shares of common stock at a weighted average price of $160.32 and an additional 246 shares at a weighted average price of $161.15.
• On January 29, 2026, Mr. Hume exercised another 25,000 employee stock options at a price of $107.32 per share, acquiring 25,000 shares of common stock.
• Following this second option exercise on January 29, 2026, Mr. Hume sold 18,080 shares of common stock at a weighted average price of $160.50 and an additional 6,920 shares at a weighted average price of $161.12.
• All reported stock option exercises and sales were conducted pursuant to a Rule 10b5-1 trading plan adopted by Mr. Hume on July 14, 2025.
• After these transactions, Mr. Hume's direct beneficial ownership of common stock is 47,515 shares, and his beneficial ownership of employee stock options is 18,857.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral. It reports routine insider transactions executed under a pre-planned 10b5-1 program, which typically carries minimal implications for the company's operational or financial outlook.

Positives

• The reporting person, Richard T. Hume, realized a profit by exercising stock options at $107.32 per share and selling the acquired common stock at significantly higher prices, ranging from $160.00 to $161.52.
• The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, indicating a structured and pre-determined approach to managing equity holdings rather than a reaction to immediate market conditions.

Negatives

• The director's overall direct beneficial ownership of common stock decreased from 60,506 shares (before the second set of transactions) to 47,515 shares, and derivative ownership decreased from 43,857 to 18,857 options, representing a reduction in direct equity exposure to the company.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those executed under Rule 10b5-1 plans, are a routine aspect of executive compensation and personal financial management within the technology distribution industry. These pre-scheduled sales are generally not indicative of a change in company fundamentals or a specific market outlook.

Stakeholder Impact

• Shareholders: The sale of shares by a director, even under a 10b5-1 plan, slightly reduces insider ownership, which some investors might view as a minor negative, though it's a common practice for liquidity and diversification.
• Employees: No direct impact on employees is indicated by this insider transaction report.

Key Dates

Recommendation

Based solely on this Form 4 filing, a seasoned investor or institution would likely maintain a 'hold' recommendation. The transactions are routine insider sales executed under a pre-established 10b5-1 plan, which typically does not signal a change in the company's fundamental prospects or warrant a shift in investment strategy. The sales are for personal financial management rather than a reaction to new company-specific information.

Keywords

SNX, TD SYNNEX, Insider Trading, Form 4, Director Stock Sale, Stock Options, 10b5-1 Plan, Equity Compensation